A Placebo-Controlled Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
A Placebo-Controlled Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia
Inclusion Criteria: